Literature DB >> 17114011

Hospital readmission after pancreaticoduodenectomy.

Dawn M Emick1, Taylor S Riall, John L Cameron, Jordan M Winter, Keith D Lillemoe, Joann Coleman, Patricia K Sauter, Charles J Yeo.   

Abstract

Data exist on the morbidity and mortality of patients undergoing pancreaticoduodenectomy (PD), but there are few reports about hospital readmissions after this procedure. Our aim was to evaluate the number of and reasons for readmission after PD and the factors influencing readmission. We reviewed the initial hospitalization and readmissions for 1643 patients undergoing PD compared patients requiring readmission to patients that did not require readmission. Twenty-six percent of patients were readmitted a total of 678 times after PD. Patients readmitted were younger than those not readmitted (61.8 versus 64.6 years, P < 0.0001). Vessel resection, abscess formation, wound infection, postoperative percutaneous biliary stents, estimated blood loss >1000 ml, and age < or =65 years were independently associated with readmission. The length of stay for all patients decreased over time, from 10.5 days in 1996 to 7 days in 2003. The percentage of patients being readmitted also decreased from 33% in 1996 to 20% (P = 0.004) in 2003. The readmission rate after PD was 26%. Younger age, blood loss, postoperative complications, and vessel resection were independent risk factors for readmission. The early hospital readmission rate has not increased in association with a decreased LOS, supporting the idea that reduction in LOS did not lead to increased readmission rates.

Entities:  

Mesh:

Year:  2006        PMID: 17114011     DOI: 10.1016/j.gassur.2006.08.016

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  36 in total

1.  Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality.

Authors:  A S Rosemurgy; M Bloomston; F M Serafini; B Coon; M M Murr; L C Carey
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

Review 2.  Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy.

Authors:  S P Povoski; M S Karpeh; K C Conlon; L H Blumgart; M F Brennan
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

3.  The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma.

Authors:  G Crile
Journal:  Surg Gynecol Obstet       Date:  1970-06

4.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

5.  Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula.

Authors:  John W Lin; John L Cameron; Charles J Yeo; Taylor S Riall; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

6.  Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy.

Authors:  G A Porter; P W Pisters; C Mansyur; A Bisanz; K Reyna; P Stanford; J E Lee; D B Evans
Journal:  Ann Surg Oncol       Date:  2000-08       Impact factor: 5.344

7.  Do preoperative biliary stents increase postpancreaticoduodenectomy complications?

Authors:  T A Sohn; C J Yeo; J L Cameron; H A Pitt; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

8.  Critical path method: an important tool for coordinating clinical care.

Authors:  P A Hofmann
Journal:  Jt Comm J Qual Improv       Date:  1993-07

9.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  49 in total

1.  Risk factors for 30-day hospital readmission among general surgery patients.

Authors:  Michael T Kassin; Rachel M Owen; Sebastian D Perez; Ira Leeds; James C Cox; Kurt Schnier; Vjollca Sadiraj; John F Sweeney
Journal:  J Am Coll Surg       Date:  2012-06-21       Impact factor: 6.113

2.  Pancreaticoduodenectomy: outcomes in a low-volume, specialised Hepato Pancreato Biliary unit.

Authors:  H A Kanhere; M I Trochsler; M H Kanhere; A N Lord; G J Maddern
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

3.  Predictors of Short-Term Readmission After Pancreaticoduodenectomy.

Authors:  Rajesh Ramanathan; Travis Mason; Luke G Wolfe; Brian J Kaplan
Journal:  J Gastrointest Surg       Date:  2018-02-05       Impact factor: 3.452

4.  Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis.

Authors:  Gaya Spolverato; Hadia Maqsood; Alessandro Vitale; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; T Clark Gamblin; Carlo Pulitano; Todd W Bauer; Feng Shen; George Poultsides; Shishir Maithel; J Wallis Marsh; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-04-23       Impact factor: 3.452

5.  Thirty days are inadequate for assessing readmission following complex hepatopancreatobiliary procedures.

Authors:  Maria S Altieri; Jie Yang; Donglei Yin; Konstantinos Spaniolas; Mark Talamini; Aurora Pryor
Journal:  Surg Endosc       Date:  2018-12-10       Impact factor: 4.584

6.  One-year readmission rates at a high volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and vertical banded gastroplasty-Roux-en-Y gastric bypass.

Authors:  John Saunders; Garth H Ballantyne; Scott Belsley; Daniel J Stephens; Amit Trivedi; Douglas R Ewing; Vincent A Iannace; Rafael F Capella; Annette Wasileweski; Steven Moran; Hans J Schmidt
Journal:  Obes Surg       Date:  2008-05-02       Impact factor: 4.129

Review 7.  Adjuvant pharmacotherapy in the management of elderly patients with pancreatic cancer.

Authors:  Raphaël Maréchal; Anne Demols; Jean-Luc Van Laethem
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

8.  Readmission following pancreatectomy: what can be improved?

Authors:  Charity C Glass; Stephen P Gondek; Charles M Vollmer; Mark P Callery; Tara S Kent
Journal:  HPB (Oxford)       Date:  2013-03-12       Impact factor: 3.647

9.  A 6-day clinical pathway after a pancreaticoduodenectomy is feasible, safe and efficient.

Authors:  Dustin M Walters; Patrick McGarey; Damien J LaPar; Aimee Strong; Elizabeth Good; Reid B Adams; Todd W Bauer
Journal:  HPB (Oxford)       Date:  2012-12-02       Impact factor: 3.647

10.  Readmission after pancreatectomy for pancreatic cancer in Medicare patients.

Authors:  Deepthi M Reddy; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin; Taylor S Riall
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.